Page last updated: 2024-08-05 11:26:26

oxindoles

Any member of the class of indolones whose structure is based on an oxindole (2-indolone) skeleton.

ChEBI ID: 38459

Members (14)

MemberDefinitionRole
2-oxindole-3-acetic acidA member of the class of oxindoles that is 2-oxindole carrying a carboxymethyl substituent at position 3.2-oxindole-3-acetic acid
3-hydroxy-2-oxoindoleAn oxindole that is 1,3-dihydro-2H-indol-2-one substituted by a hydroxy group at position 3.3-hydroxyindolin-2-one
3-hydroxy-3-methyloxindoleA methylindole that is 1,3-dihydro-2H-indol-2-one substituted by methyl and a hydroxy group at position 3.3-hydroxy-3-methyloxindole
3-methyleneoxindole3-methyleneoxindole
3-methyloxindoleA member of the class of oxindoles that is oxindole (1,3-dihydro-2H-indol-2-one) in which one of the hydrogens at position 3 has been replaced by a methyl group.3-methyloxindole
DDR1-IN-1A secondary carboxamide resulting from the formal condensation of the carboxy group of 4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)benzoic acid with the amino group of 5-(5-amino-2-methylphenoxy)-1,3-dihydro-2H-indol-2-one. It is a potent inhibitor of discoidin domain receptor tyrosine kinase 1 and 2 (DDR1/2) with IC50 = 105 nM and 413 nM, respectively.DDR1-IN-1
LY-310762A member of the class of oxindoles that is 1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-one in which the ethyl group has been substituted at position 2 by a 4-(p-fluorobenzoyl)piperidin-1-yl group. It is a potent and selective antagonist for the 5-hydroxytryptamine 1D (5-HT1D) receptor.LY-310762
MI-63An azaspiro compound resulting from the formal fusion of position 3 of 6-chloro-oxindole with position 3 of (2R,3SS5S)-3-(3-chloro-2-fluorophenyl)-5-(2,2-dimethylpropyl)-N-[2-(morpholin-4-yl)ethyl]pyrrolidine-2-carboxamide. It is a potent inhibitor of the MDM2-p53 interaction.MI-63
orantinibAn oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is substituted by a 2-(2-carboxyethyl)-3,5-dimethylpyrrol-3-yl group. It is an ATP-competitive inhibitor of the tyrosine kinase activity of fibroblast growth factor receptor 1.orantinib
semaxinibAn oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is replaced by a 3,5-dimethylpyrrol-2-yl group.semaxanib
su 11652A member of the class of pyrrolecarboxamides obtained by formal condensation of the carboxy group of 5-[(Z)-(5-chloro-2-oxo-1,2-dihydroindol-3-ylidene)methyl]-2,4-dimethylpyrrole-3-carboxylic acid with the primary amino group of N(1),N(1)-diethylethane-1,2-diamine.SU11652
su 5614A member of the class of oxindoles that is 5-chlorooxindole in which the two hydrogens at position 3 are replaced by a (3,5-dimethylpyrrol-2-yl)methylidene group.SU5614
SU5402An oxindole that is 3-methyleneoxindole in which one of the hydrogens of the methylene group is substituted by a 3-(2-carboxyethyl)-4-methyl-1H-pyrrol-2-yl group. It is an ATP-competitive inhibitor of the tyrosine kinase activity of fibroblast growth factor receptor 1.SU5402
SU6656A member of the class of oxindoles that is 3-methyleneoxindole in which the hydrogeh at position 5 has been replaced by a dimethylaminosulfonyl group and in which one of the hydrogens of the methylene group has been replaced by a 4,5,6,7-tetrahydro-indol-2-yl group. It is a specific inhibitor of Src family kinase.SU6656

Research

Studies (547)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19909 (1.65)18.7374
1990's11 (2.01)18.2507
2000's251 (45.89)29.6817
2010's230 (42.05)24.3611
2020's46 (8.41)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials31 (5.09%)5.53%
Reviews43 (7.06%)6.00%
Case Studies8 (1.31%)4.05%
Observational0 (0.00%)0.25%
Other527 (86.54%)84.16%